🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to compare how 2 different drug...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2014-10-13
Trial ID
NCT02269280
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Status
Completed
Location
Hospital Universitario Príncipe de Asturias
Start Date
2020-11-04
Trial ID
NCT04687761
Treatments Being Tested
To evaluate the efficacy and safety of low-dose decitabine combined with ti...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05638984
Treatments Being Tested
This Phase 1/2 study will evaluate the safety, efficacy, PK, and PD of FT-2...
Status
Completed
Location
UCLA Medical Center
Start Date
2016-04-30
Trial ID
NCT02719574
Treatments Being Tested
This phase II trial tests how well venetoclax with cladribine and cytarabin...
Status
Recruiting
Location
University of Miami Miller School of Medicine-Sylvester Cancer Center
Start Date
2025-01-03
Trial ID
NCT06504459
This is a Phase I/II clinical study to determine the maximum tolerated dose...
Status
Terminated
Location
Research Site
Start Date
2017-07-31
Trial ID
NCT03217838
Treatments Being Tested
To study if decitabine can help to control Myelodysplastic Syndrome (MDS) i...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2005-03
Trial ID
NCT00113321
Treatments Being Tested
Primary Objective: 1\. To evaluate side effects and maximum tolerated dose...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2005-05
Trial ID
NCT00496444
Treatments Being Tested
This study is an open-label phase II trial to investigate the efficacy and ...
Status
Completed
Location
Medizinische Hochschule Hannover
Start Date
2003-04
Trial ID
NCT00866073
Treatments Being Tested
A randomized，multicenter, open-label Phase III, clinical study is conducted...
Status
Recruiting
Location
the First Affiliated Hospital,College of Medicine,Zhejiang University
Start Date
2023-03-03
Trial ID
NCT05586074
Treatments Being Tested